Effects of herbal medicine (Danggwijagyaksan) for treating climacteric syndrome with a blood-deficiency-dominant pattern: A randomized, double-blind, placebo-controlled pilot trial

被引:6
作者
Park, Eun-Ji [1 ]
Baek, Seon-Eun [2 ]
Kim, Mikyung [3 ]
Kim, Ae-Ran [4 ]
Park, Hyo-Ju [4 ]
Kwon, Ojin [4 ]
Lee, Jun-Hwan [4 ]
Yoo, Jeong-Eun [5 ]
机构
[1] Daejeon Univ, Dept Obstet & Gynecol, Cheonan Korean Med Hosp, Cheonan, South Korea
[2] Daejeon Univ, Dept Obstet & Gynecol, Seoul Korean Med Hosp, Seoul, South Korea
[3] Sangji Univ, Coll Korean Med, Dept Internal Med, Wonju, South Korea
[4] Korea Inst Oriental Med, Clin Med Div, 1672 Yuseong Daero, Daejeon 34054, South Korea
[5] Daejeon Univ, Coll Korean Med, Dept Obstet & Gynecol, Daejeon 35235, South Korea
关键词
Herbal medicine; Climacteric syndrome; Danggwijagyaksan; Menopause; Complementary and alternative medicine; TRADITIONAL CHINESE MEDICINE; TOKI-SHAKUYAKU-SAN; MENOPAUSAL SYMPTOMS; POSTMENOPAUSAL WOMEN; PRESCRIPTION PATTERN; IRON PREPARATION;
D O I
10.1016/j.imr.2021.100715
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Danggwijagyaksan (DJS) has been one of the most widely used herbal medicines for gynecological disorders in traditional East Asian medicine. Several clinical studies about DJS have shown improvement in menopausal symptoms. This pilot study aimed to evaluate the efficacy, safety and feasibility of DJS for treating climacteric syndrome with a blood-deficiency-dominant pattern. Methods: This was a randomized, double-blind, placebo-controlled pilot trial. A group of 45-to 60-year old women with climacteric syndrome were registered for the trial. The participants received treatment over a 4-week period and were then followed for 4 weeks. The primary outcome measure was the mean change in the Menopause Rating Scale (MRS). Secondary outcome measures included the World Health Organization Quality of Life-BREF (WHOQOL-BREF), the Blood-Deficiency Scoring System (BDSS), lean body mass, and serum hormone levels, including follicle-stimulating hormone (FSH) and estradiol (E-2) levels. Results: The MRS and BDSS scores decreased significantly in both groups, but the differences between two groups were not significant. The WHOQOL-BREF scores increased in the control group. No statistically meaningful differences in serum hormone levels or lean body mass were observed in both groups. There were no serious adverse events, and the laboratory tests were within the normal range. The recruitment rate, completion rate and medication adherence rate were over 90% in both groups, indicating high feasibility. Conclusions: DJS showed clinical effectiveness in the treatment of climacteric syndrome with a blood deficiency-dominant pattern. Additionally, DJS was shown to be safe and feasible for a large-scale study to confirm the efficacy of the treatment. Trial registration: Clinical Research Information Service (CRIS, https://cris.nih.go.kr ): KCT0 0 02387. (c) 2021 Published by Elsevier B.V. on behalf of Korea Institute of Oriental Medicine. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页数:7
相关论文
共 36 条
[1]   Successful treatment of intractable menstrual migraine with the traditional herbal medicine tokishakuyakusan [J].
Akaishi, Tetsuya ;
Takayama, Shin ;
Ohsawa, Minoru ;
Kikuchi, Akiko ;
Arita, Ryutaro ;
Nakashima, Ichiro ;
Aoki, Masashi ;
Ishii, Tadashi .
JOURNAL OF GENERAL AND FAMILY MEDICINE, 2019, 20 (03) :118-121
[2]   A comparative study of laboratory parameters and symptoms effected by Toki-Shakuyaku-San and an iron preparation in rats with iron-deficiency anemia [J].
Akase, T ;
Onodera, S ;
Matsushita, R ;
Akase, T ;
Tashiro, S .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (06) :871-878
[3]   A comparative study of the usefulness of Toki-shakuyaku-san and an oral iron preparation in the treatment of hypochromic anemia in cases of uterine myoma [J].
Akase, T ;
Akase, T ;
Onodera, S ;
Jobo, T ;
Matsushita, R ;
Kaneko, M ;
Tashiro, S .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2003, 123 (09) :817-824
[4]   Assessment of blinding in clinical trials [J].
Bang, HJ ;
Ni, LY ;
Davis, CE .
CONTROLLED CLINICAL TRIALS, 2004, 25 (02) :143-156
[5]  
박제민, 2007, [The Journal of Oriental Obstetrics & Gynecology, 대한한방부인과학회지], V20, P213
[6]   A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages [J].
Fu, Shu-fei ;
Zhao, Ying-qiang ;
Ren, Ming ;
Zhang, Jun-hua ;
Wang, Yue-fei ;
Han, Li-feng ;
Chang, Yan-xu ;
Fan, Guan-wei ;
Wang, Hong ;
Huang, Yu-hong ;
Zhai, Jing-bo ;
Dong, Jin-ying ;
Li, Xin ;
Ai, Ju-qing ;
Zhang, Han ;
Zhu, Yan ;
Zhang, Bo-li ;
Sun, Li-kang ;
Fan, Xiang ;
Gao, Xiu-mei .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (03) :311-323
[7]   A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women [J].
Haines, C. J. ;
Lam, P. A. ;
Chung, T. K. H. ;
Cheng, K. F. ;
Leung, P. C. .
CLIMACTERIC, 2008, 11 (03) :244-251
[8]   The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study [J].
Heinemann L.A.J. ;
DoMinh T. ;
Strelow F. ;
Gerbsch S. ;
Schnitker J. ;
Schneider H.P.G. .
Health and Quality of Life Outcomes, 2 (1)
[9]  
Ishida K, 2009, KAMPO MED, V60, P61
[10]  
한숙영, 2004, [The Journal of Korean Oriental Internal Medicine, 대한한방내과학회지], V25, P224